bpc 157 huberman lab Yes, BPC-157 is the world's most hyped peptide these days. But . . . does it REALLY deliver on all that Wolverine-ish talk? World's Strongest Man Mitchell Hooper and Ebenezer Samuel, CSCS Renowned neuroscientist Andrew Huberman shares

Reduced cobalamin availability leads to: Impaired enterocyte regeneration Villous atrophy and barrier dysfunction Increased intestinal permeability Secondary dysbiosis and chronic inflammation Clinically, this manifests as: Persistent anorexia Weight loss Chronic diarrhea Poor response to standard GI or pancreatitis therapy Low vitamin B12 concentrations have also been associated with increased disease severity and poorer prognosis in dogs with chronic enteropathy and inflammatory bowel disease

Sometimes it turns out to be a number on a lab report

Timing: Morning injections are preferred, aligning with natural circadian fat metabolism

Interest in cobalt compounds was renewed by Mushett et al

(2022a, August 17)